Cerium Pharmaceuticals is dedicated to creating efficacious therapies for patients with kidney diseases. Cerium is currently focused on developing the first drug approved for a very rare kidney disease called Primary Membranous Nephropathy (PMN). There are approximately 75,000 PMN patients in the US and approximately 3,000 newly diagnosed PMN patients per year.
View Top Employees from Cerium PharmaceuticalsWebsite | http://www.ceriumpharma.com |
Revenue | $6 million |
Employees | 4 (4 on RocketReach) |
Founded | 2012 |
Address | 312 Main St Ste 200, Gaithersburg, Maryland 20878, US |
Phone | (301) 963-2400 |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Health Care, Rare Diseases, Manufacturing, Medical Device, Orphan Drugs, Pharmaceutical |
Web Rank | 23 Million |
Keywords | Cerium Pharma |
Competitors | 4P Therapeutics, Haffner Associates, LLC, Immunohelix |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Cerium Pharmaceuticals employee's phone or email?
The Cerium Pharmaceuticals annual revenue was $6 million in 2024.
Nancy Klett is the COO of Cerium Pharmaceuticals.
4 people are employed at Cerium Pharmaceuticals.
Cerium Pharmaceuticals is based in Gaithersburg, Maryland.
The NAICS codes for Cerium Pharmaceuticals are [32541, 32, 3254, 325].
The SIC codes for Cerium Pharmaceuticals are [283, 28].